BioXcel Therapeutics Inc.
0.35
-0.01 (-1.88%)
At close: Jan 15, 2025, 2:43 PM

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
PE Ratio -0.48 -3.5 -5.03 -12.22 -7.36 -2.92 -36.91 -81.4 -276.46
PS Ratio 62.27 1.60K n/a n/a n/a n/a n/a n/a n/a
PB Ratio -1.52 7.84 2.42 4.85 8.85 1.45 -170.63 -532.62 n/a
P/FCF Ratio -0.55 -4.44 -6.49 -15.03 -8.45 -4.06 -76.3 -132.95 -625.73
P/OCF Ratio -0.55 -4.45 -6.53 -15.1 -8.72 -4.16 -76.3 -133.36 -627.96
OCF/S Ratio -112.32 -360.91 n/a n/a n/a n/a n/a n/a n/a
Debt / Equity Ratio -1.79 1.23 0.01 0.01 0.04 n/a -0.38 n/a n/a
Quick Ratio 2.57 6.11 13.98 18.33 4.03 9.26 0.38 0.01 n/a
Current Ratio 2.65 6.17 13.98 18.33 4.03 9.26 0.38 0.01 n/a
Asset Turnover 0.02 0.00 n/a n/a n/a n/a n/a n/a n/a
Interest Coverage -12.9 -19.44 -2.67K -3.05K n/a n/a -2.27K n/a n/a
Return on Equity (ROE) 3.17 -2.24 -0.48 -0.4 -1.2 -0.5 4.62 6.54 n/a
Return on Assets (ROA) -2.43 -0.83 -0.45 -0.37 -0.89 -0.44 -3.35 -302.86 n/a
Return on Capital (ROIC) -3.7 -0.92 -0.48 -0.4 -1.2 -0.51 4.62 6.54 n/a
Dividend Yield n/a n/a n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin 8.70% 94.67% n/a n/a n/a n/a n/a n/a n/a
Net Profit Margin -12.97K% -45.83K% n/a n/a n/a n/a n/a n/a n/a
Pretax Profit Margin -12.97K% -44.20K% n/a n/a n/a n/a n/a n/a n/a
Operating Profit Margin -12.45K% -42.57K% n/a n/a n/a n/a n/a n/a n/a
FCF Margin -11.23K% -36.13K% n/a n/a n/a n/a n/a n/a n/a
EBITDA Margin -11.99K% -41.97K% n/a n/a n/a n/a n/a n/a n/a

Create Price Alert on BTAI

Your price alert will notify you when the stock price is above 0.35.

Add to Watchlist